ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2

More in Science

• STAT+: After a cancer vaccine’s first success, the race is on to expand the impact

  Merck and Moderna’s Intismeran cancer vaccine, when combined with Keytruda, showed a 42% reduction in the risk of recurrence or death, marking a significant improvement over the long history of cancer vaccines. This breakthrough has sparked a race to expand its impact, with experts suggesting this approach may be applicable to other types of tumors. This development holds the potential to transform the field of cancer treatment, offering hope to patients and researchers alike.

  1 min read
• From unfinished books to 10-second reels: Is reading becoming lost art?

  Harper Lee’s words, “Until I feared I would lose it, I never loved to read,” resonate with the urgency of the times. The relationship between readers and books is changing, but the deeper question is what this change is doing to our capacity for attention, reflection, and understanding. The loss of deep reading weakens the research culture NEP 2020 seeks to build, the multidisciplinary synthesis it promotes, and the capacity of graduates to contribute to public life with reasoned judgment rather than reactive opin…

  9 min read
• NCERT rolls out 20-hour AI module for classes 9-12

  NCERT introduces a 20-hour AI module for classes 9-12, focusing on critical thinking, creativity, and responsible AI use. The module, developed in consultation with IIT Madras and IIT Jodhpur, promotes ethical and safe technology practices.

  1 min read